Vector-Based Comparison and Average Slope Can Refine Bioequivalence Claims: A Machine and Deep Learning Approach.

Maria Kokkali1, Vangelis D Karalis1,2

  • 1Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.

PubMed
Summary

Two new methods, absorption rates (AS) and vector-based clinical endpoints (VBC), enhance bioequivalence studies. Combining AS and VBC improves accuracy, reduces variability, and lowers costs for drug development.

Related Concept Videos

Average and Instantaneous Velocity Vectors01:12

Average and Instantaneous Velocity Vectors

To calculate other physical quantities in kinematics, the time variable must be introduced. The time variable not only allows us to state where an object is (its position) during its motion, but also how fast it’s moving. The speed at which an object is moving is given by the rate at which the position changes with time. For each position, a particular time is assigned. If the details of the motion at each instant are not important, the rate is usually expressed as the average velocity v.
8.8K
The Sense of Self: Reflected Self-Appraisal and Social Comparison02:57

The Sense of Self: Reflected Self-Appraisal and Social Comparison

According to Charles Cooley, we base our image on what we think other people see (Cooley 1902). We imagine how we must appear to others, then react to this speculation. We don certain clothes, prepare our hair in a particular manner, wear makeup, use cologne, and the like—all with the notion that our presentation of ourselves is going to affect how others perceive us. We expect a certain reaction, and, if lucky, we get the one we desire and feel good about it. But more than that, Cooley...
56.2K
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.0K
Testing a Claim about Mean: Known Population SD01:11

Testing a Claim about Mean: Known Population SD

A complete procedure of testing the hypothesis about a population mean is explained here.
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
3.3K
Average Acceleration01:30

Average Acceleration

The importance of understanding acceleration spans our day-to-day experiences, as well as the vast reaches of outer space and the tiny world of subatomic physics. In everyday conversation, to accelerate means to speed up. For instance, we are familiar with the acceleration of our car; the harder we apply our foot to the gas pedal, the faster we accelerate. The greater the acceleration, the greater the change in velocity over a given time. Acceleration is widely seen in experimental physics. In...
14.5K
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
4.0K